Skip to main content
. 2014 Sep 2;2014(9):CD000963. doi: 10.1002/14651858.CD000963.pub3

Tavafian 2008.

Methods RCT conducted in Iran
Participants Adult women recruited from outpatient rheumatology clinics with age >18 years, LBP >3 months. 102 patients randomised, 100% female, average age 42.9 years, mean duration of pain 9.1 months
Interventions MBR (Education): 4 days, 5 sessions, based on Back school. Education: anatomy, physiology, pathology of LBP, self‐care, health behaviours, biomechanics, lifestyle factors, prevention. Psychologist: coping skills, anger management, relaxation. Physiotherapist: stretching, strengthening, posture, functional movement advice (HEP)
Usual (Control): medical management, mostly medication prescription (analgesics, muscle relaxants, NSAIDs, anti‐depressants)
Outcomes Pain (SF‐36 bodily pain), General Health (SF‐36)
Follow‐ups: ST (3 months), MT (6 months), LT (12 months)
Notes Subgroup analyses: Mid‐intensity intervention, Low baseline symptom intensity (<60% of maximum scale score)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Unclear
Allocation concealment (selection bias) High risk pg.1618 1st column. "The treatment allocation was not concealed"
Blinding of participants High risk Not possible
Blinding of clinicians High risk Not possible
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Not possible; patient reported outcome
Incomplete outcome data (attrition bias) 
 All outcomes High risk pg.1618 Fig 1. 74/102 randomized patients followed up
Intention to treat analysis Unclear risk Unclear
Selective reporting (reporting bias) Unclear risk No protocol
Comparability of groups at baseline Low risk Table 1. Groups comparable on relevant demographic and clinical variables
Compliance Unclear risk No stated
Cointerventions Low risk pg.1618 1st column. "cointerventions were avoided for both group"
Timing of assessment Low risk pg 1617 Study Design. "This was a blind randomized controlled trial with a 3, 6, and 12 months follow up"